DEEP Platform Showcases

Discover concise spotlights on high‑value digital measures - curated for teams needing fast, credible insight. Each article distills structured evidence from the DEEP Platform into clear takeaways you can use to assess relevance, maturity, and regulatory readiness. Perfect for teams evaluating new endpoints, shaping strategy, or exploring what 'good' looks like in digital measurement.
Subscribe
All categories Best practices Clinical studies Digital Measurement Solution Engagement Opportunity Functional Mobility Measurement Definition Myasthenia Gravis Nocturnal Monitoring Obstructive Sleep Apnea Parkinson's Disease Rare Diseases Regulatory Respiratory Conditions Sleep Quality
Digital Measurement Solution Respiratory Conditions Nocturnal Monitoring Engagement Opportunity

Digital Measure Collaboration: Sleepiz One+ for Nocturnal Monitoring in Respiratory Clinical Trials

Chronic respiratory diseases like COPD, asthma, and IPF are 24-hour conditions, yet clinical trials often rely solely on daytime measurements, leaving a critical evidence gap. Pharmaceutical leaders...
Team DEEP Measures
Parkinson's Disease Measurement Definition Functional Mobility Engagement Opportunity

Measuring Functional Mobility in Parkinson's Disease (PD)

Mobility problems don't just affect movement; they erode self-confidence and increase the risk of hospitalization. While standard clinic tests capture a snapshot, they miss the 24-hour reality of...
Team DEEP Measures
Digital Measurement Solution Respiratory Conditions Rare Diseases Sleep Quality Engagement Opportunity

Digital Measure Collaboration: Sleepiz One+ for Sleep & Respiratory Endpoints in Rare Disease Clinical Trials

Chronic respiratory diseases like COPD, asthma, and IPF are 24-hour conditions, yet clinical trials often rely solely on daytime measurements, leaving a critical evidence gap. Pharmaceutical leaders...
Team DEEP Measures
Measurement Definition Myasthenia Gravis Engagement Opportunity

Call for Collaborators to Define New Digital Measures in Myasthenia Gravis

Developing precise and comprehensive digital measures for Myasthenia Gravis (MG) that capture meaningful aspects of the disease and address unmet needs in patient care and drug development.
Team DEEP Measures
Digital Measurement Solution Nocturnal Monitoring Engagement Opportunity Obstructive Sleep Apnea

Digital Measure Collaboration: Sleepiz One+ for OSA Endpoints in Metabolic Clinical Trials

Following the precedent set by successful GLP-1 trials in Obstructive Sleep Apnea (OSA), expansion of drug labels into this highly prevalent and impactful condition is the new frontier for metabolic...
Team DEEP Measures
Best practices Engagement Opportunity Regulatory

Navigating Health Technology Assessment (HTA) ​Expectations for Digital Measure Approval

Why is this important? Accelerating and widening access to safe, effective and innovative health technologies that bring value to patients and the healthcare system is essential for improving health...
Team DEEP Measures
Clinical studies Digital Measurement Solution Respiratory Conditions

Translating Breathlessness into Digital Signals in COPD

A quick look at how Respiratory Rate (RR) connects the lived experience of COPD breathlessness with an objective digital signal. Relevant for Market Access teams, Data Scientists, IT/Digital Health...
Team DEEP Measures